Milbemycin Oxime
CAS number: 129496-10-2
Molecular formula: 2C32H45NO7.2C31H43NO7
molecular weight: 2194.7
Chemical structure:
Producers shown on SFDA
(Record date:01/11/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Zhejiang Hisun Pharmaceutical Co.,Ltd. | GMP | Valid till July 2025 |
Producers shown on EP
(Quoted from EP website;record date:01/11/2021)
Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
Milbemycin oxime for veterinary use | HUBEI HONCH PHARMACEUTICAL CO., LTD. Qichun County CN | R0-CEP 2018-025 - Rev 02 | 02/06/2020 | Valid | / | Chemical |
Milbemycin oxime for veterinary use | LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Jiangyin CN | R0-CEP 2018-024 - Rev 02 | 15/12/2020 | Valid | / | Chemical |
Milbemycin oxime for veterinary use | LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO., LTD. Jiangyin CN | R0-CEP 2020-124 - Rev 01 | 04/03/2021 | Valid | / | Chemical |
Producer:Zhejiang Hisun Pharmaceutical Co.,Ltd., founded in 1956, is one of the largest production bases of antibiotics and antitumor drugs in China.
Headquartered in Taizhou, the company has established integrated pharmaceutical bases in Taizhou, Zhejiang, Fuyang, Hangzhou and Rudong, Jiangsu. The research, development and production of drug treatment fields cover anti-tumor, anti infection, cardiovascular, endocrine, immunosuppression, antidepressant, orthopedics, etc. The company has more than 40 varieties officially certified by FDA of the United States, EDQM of the European Union, TGA of Australia and KFDA of Korea.
Staff size:About 8500 people
Registered capital:RMB 1 billion 196 million
Website: http://www.hisunpharm.com
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978